The competitive landscape for the development of the PD-(L)1xVEGF bispecific therapy is heating up, with several pharmaceutical companies vying for dominance. This race centers...
Pfizer has secured a significant victory in the competitive pharmaceutical landscape by placing a $10 billion bid for obesity drug developer Metsera, surpassing an...
Pfizer has successfully negotiated a **’most favored nation’ deal**, a significant move that could reshape its pricing strategies within the pharmaceutical sector. This agreement,...